We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
Turnover
31.08%
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.92%
AUM
$45.9B
AUM Growth
+$3.99B
(+9.5%)
Cap. Flow
+$3.07B
Cap. Flow % of AUM
Cap. Flow %
6.69%
Top 10 Holdings %
Top 10 Hldgs %
9.34%
Holding
3,639
New
509
Increased
1,872
Reduced
840
Closed
385
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.79% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 9.88% |
| 5 | Consumer Staples | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$172B
| $749M | 1.63% |
25,797,600
-544,400
| -2% | -$15.1M |
2013 Q2
10 quarters
|
|
2
Colgate-Palmolive
CL
$73.7B
| $670M | 1.46% |
10,062,900
-1,374,800
| -12% | -$91.5M |
2013 Q2
10 quarters
|
|
|
3
Apple
AAPL
$5.07T
| $470M | 1.02% |
+17,852,932
| New | +$510M |
2015 Q4
0 quarters
|
|
4
VeriSign
VRSN
$27B
| $426M | 0.93% |
4,876,476
-137,600
| -3% | -$11.5M |
2013 Q2
10 quarters
|
|
5
Alaska Air
ALK
$3.95B
| $386M | 0.84% |
4,799,500
-715,221
| -13% | -$56.6M |
2013 Q2
10 quarters
|
|
6
NetEase
NTES
$73.2B
| $362M | 0.79% |
9,980,500
-2,946,000
| -23% | -$91.7M |
2013 Q2
10 quarters
|
|
|
LLTC
7
DELISTED
Linear Technology Corp
LLTC
| $326M | 0.71% |
7,681,200
+19,000
| +0.2% | +$835K |
2013 Q2
10 quarters
|
|
8
Ryanair
RYAAY
$27.5B
| $308M | 0.67% |
8,911,798
+773,887
| +10% | +$25.3M |
2013 Q2
10 quarters
|
|
9
Mastercard
MA
$535B
| $294M | 0.64% |
3,021,400
+205,800
| +7% | +$20.2M |
2013 Q2
10 quarters
|
|
10
Domino's
DPZ
$10.2B
| $294M | 0.64% |
2,639,900
-180,500
| -6% | -$19.3M |
2013 Q2
10 quarters
|
|
11
Cboe Global Markets
CBOE
$34.2B
| $286M | 0.62% |
4,399,700
+176,000
| +4% | +$11.9M |
2013 Q2
10 quarters
|
|
12
Novartis
NVS
$296B
| $266M | 0.58% |
3,449,777
+1,572,221
| +84% | +$125M |
2013 Q3
9 quarters
|
|
|
13
Pfizer
PFE
$170B
| $258M | 0.56% |
+8,416,549
| New | +$265M |
2015 Q4
0 quarters
|
|
14
Palo Alto Networks
PANW
$326B
| $239M | 0.52% |
8,142,000
+4,361,400
| +115% | +$126M |
2015 Q2
2 quarters
|
|
|
15
Gilead Sciences
GILD
$196B
| $235M | 0.51% |
2,319,448
+2,039,148
| +727% | +$212M |
2014 Q4
4 quarters
|
|
16
Duke Energy
DUK
$97B
| $229M | 0.5% |
3,208,267
+143,800
| +5% | +$10.1M |
2014 Q1
7 quarters
|
|
17
Coca-Cola
KO
$397B
| $217M | 0.47% |
5,049,399
+1,753,300
| +53% | +$74.4M |
2014 Q3
5 quarters
|
|
18
Allegiant Air
ALGT
$1.94B
| $212M | 0.46% |
1,263,100
+11,900
| +1% | +$2.29M |
2013 Q2
10 quarters
|
|
19
DELISTED
AvalonBay Communities
AVB
| $210M | 0.46% |
1,138,514
+278,100
| +32% | +$49.8M |
2014 Q3
5 quarters
|
|
|
BCR
20
DELISTED
CR Bard Inc.
BCR
| $208M | 0.45% |
1,098,500
+207,600
| +23% | +$38.9M |
2013 Q2
10 quarters
|
|
21
Hershey
HSY
$33.2B
| $198M | 0.43% |
2,216,300
-299,100
| -12% | -$26.8M |
2013 Q2
10 quarters
|
|
22
Barrick Mining
B
$64B
| $190M | 0.41% |
25,706,526
+7,613,624
| +42% | +$56.8M |
2014 Q2
6 quarters
|
|
23
Huntington Ingalls Industries
HII
$11.1B
| $189M | 0.41% |
1,488,700
+14,800
| +1% | +$1.81M |
2013 Q2
10 quarters
|
|
|
24
Meta Platforms (Facebook)
META
$1.6T
| $188M | 0.41% |
+1,792,200
| New | +$184M |
2015 Q4
0 quarters
|
|
25
Clorox
CLX
$10.5B
| $187M | 0.41% |
1,473,800
-355,100
| -19% | -$44.1M |
2013 Q2
10 quarters
|
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 385 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.